Publicacións nas que colabora con Alfonso Varela Román (43)

2022

  1. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273

  2. Cardiac amyloidosis: Description of a series of 143 cases

    Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213

  3. Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

    Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428

2021

  1. A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

    Frontiers in Physiology, Vol. 12

  2. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 175-182

  3. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753

2019

  1. CHA2DS2-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

    Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology

  2. Inflammatory effects of in vivo glycated albumin from cardiovascular patients

    Biomedicine and Pharmacotherapy, Vol. 113

  3. Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure

    Journal of Cardiovascular Translational Research, Vol. 12, Núm. 3, pp. 231-239

  4. Obesity-Related Genetic Determinants of Heart Failure Prognosis

    Cardiovascular Drugs and Therapy, Vol. 33, Núm. 4, pp. 415-424

  5. P658CHA2DS2-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

    European Heart Journal, Vol. 40, Núm. Supplement_ 11, pp. ehz747.0265

  6. Prevalence and outcomes of atrial fibrillation in a European healthcare area gained through the processing of a health information technology system

    Revista Portuguesa de Cardiologia, Vol. 38, Núm. 1, pp. 21-29

  7. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 10, pp. 1050-1060

2018

  1. Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings

    Revista Espanola de Cardiologia, Vol. 71, Núm. 10, pp. 820-828

  2. Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: Impact in de novo heart failure patients

    International Journal of Medical Sciences, Vol. 15, Núm. 5, pp. 417-424

2017

  1. Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area

    International Journal of Cardiology, Vol. 243, pp. 211-215

  2. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: Relation with body composition

    Cardiovascular Diabetology, Vol. 16, Núm. 1

  3. La fracción de eyección intermedia no permite estratificar el riesgo de los pacientes hospitalizados por insuficiencia cardiaca

    Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 338-346

  4. Letter to editor in response to Formiga et al. “Utility of the Controlling Nutritional Status (CONUT) score in patients admitted due to acute heart failure”

    International Journal of Cardiology

  5. Non classical Monocytes Levels, Increased by Subcutaneous Fat-Secretome, Are Associated with Less Rehospitalization after Heart Failure Admission

    Journal of Cardiovascular Translational Research, Vol. 10, Núm. 1, pp. 16-26